GV (Google Ventures)

Activity from announced rounds

Activity in this selectionNorth America

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
34
Confirmed lead rounds
2
26 roles undisclosed
New companies
32
First participation on record · 2 follow-on
Funding in participating rounds
$21.4B
34 disclosed · full round size, not this investor’s share

By stage

Series C+11
Series B8
Series A6
Seed4
Undisclosed4
1 more
Growth1

By primary sector

Biotech7
AI6
Healthtech6
Cybersecurity5
Developer tools2
7 more
Fintech2
Climate tech1
Defense tech1
Enterprise software1
Foodtech1
Mobility1
Space tech1

By country

United States34

Rounds

34 in this selection
Humans&

Provides AI software to help people collaborate with each other

$480MSeed
Role not disclosed
EpiBiologics

Develops bispecific antibodies for targeted degradation of extracellular proteins.

$107MSeries B
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed
Prudentia Sciences

Provides AI-native due diligence for life sciences dealmaking

$20MSeries A
Role not disclosed